ABSTRACT. Interferons (IFNs) are key mediators that activate host defense mechanisms against viruses. The recently identified mammalian Type III IFN has biological effects similar to type I IFN. However, the biological effects of type III IFN have not yet been characterized in birds. We compared the effects of chicken type III IFN (IFN-λ) with type I (IFN-β) and type II (IFN-γ) IFNs on IFN-stimulated genes (ISGs) using recombinant proteins expressed in Escherichia coli. Recombinant chicken IFN-λ inhibited influenza virus replication and induced the mRNA expression of the ISGs, Mx and OAS, in chicken embryonic fibroblasts (CEFs) in a dose-dependent manner. However, the effective dose of IFN-λ was higher than that of IFN-β and IFN-γ. Furthermore, the effect of IFN-λ on induction of Mx and OAS was lesser than that of IFN-β, but comparable to that of IFN-γ. These results indicate that chicken IFN-λ has the potential to induce ISGs and inhibit viral replication in chicken cells.
Vertebrates are susceptible to viral infections, which self-replicate within the host cells. In contrast, host animals possess defense mechanisms against virus infections; these mechanisms are mediated by innate immune responses in the early phase and adaptive immune responses in the later phase. Interferons (IFNs) are key mediators that activate host defense mechanisms against viruses. In mammals, IFNs are classified into three types [7] . Type I IFNs are a large family of structurally related cytokines, including IFN-α and IFN-β. IFN-γ is the sole member of the type II IFN family. Type III IFNs have recently been identified, and they comprise IFN-λ1, IFN-λ2 and IFN-λ3, also known as interleukin (IL)-29, IL-28A and IL-28B, respectively.
Recognition of viral nucleic acids by cellular pattern recognition receptors such as retinoic acid-induced gene-I, melanoma differentiation-associated gene-5, and toll-like receptors activates production of type I IFN [7, 29] . Type I IFN binds to the type I IFN receptors, IFNAR1 and IF-NAR2, leading to phosphorylation of receptor-associated Janus kinase (JAK) each other, followed by activation of signal transducer and activator of transcription 1 (STAT1) and STAT2 [7, 29] . Consequently, the expression of various genes known as IFN-stimulated genes (ISGs) is induced [16] . The products of ISGs are known to have broad antiviral effects and to confer the "antiviral state" on IFN-stimulated cells. For example, Mx proteins are IFN-inducible GTPases that inhibit replication of orthomyxoviruses, bunyaviruses, and rhabdoviruses [9] . The 2'-5′-oligoadenylate synthetase (OAS) is also an IFN-inducible gene product. OAS is stimulated by dsRNA, and produces 2'-5′-linked oligoadenylates (2-5A), which binds to RNase L, resulting in the dimerization and activation of RNase L. Activated RNase L cleaves viral RNA transcripts as well as host RNAs [11] . In addition, type I IFN can regulate the adaptive immune response by acting directly and indirectly on natural killer (NK) cells, CD8 + cytotoxic T cells (CTLs), dendritic cells (DCs), and B cells [15, 23] .
Type II IFN is produced by CD4 + T helper 1 cells, CD8 + CTLs, and NK cells. Type II IFN binds to two receptors, IFNGR1 and IFNGR2, and induces phosphorylation of STAT1 by activation of JAKs, Jak1 and Jak2, thereby inducing the transcription of ISGs [2, 24] . Type II IFN acts on various types of immune cells and regulates innate and adaptive immunity. For example, it activates both class I and class II antigen presentation pathways by inducing MHC molecules and other related proteins. In addition, type II IFN also induces the activation of macrophages and increases microbicidal activity [24] .
Type III IFN belongs to the IL-10-like cytokine family that is produced by various types of cells [5, 14, 27, 31] . Production of type III IFN is induced following infection of viruses by the same mechanism as type I IFN [21, 22] . The receptor for type III IFN comprises two cytokine receptor family class II members, IFNLR1 and IL10R2 [5, 14, 27] . While IL10R2 is ubiquitously expressed among hematopoietic and nonhematopoietic cells, IFNLR1 has a restricted distribution and is mainly expressed in epithelial cells, hepatocytes and certain immune cells such as DCs and B cells [3, 4, 28, 32] . Binding of type III IFN to its receptor activates STATs following the phosphorylation of IL10R2-associated JAKs, Jak1 and Tyk2 [19, 32] . Consequently, type III IFN induces transcription of ISGs as well as other types of IFN.
IFNs have so far been identified in nonmammalian species such as fish and birds [26] . In birds, type I (IFN-α and IFN-β) and type II (IFN-γ) IFNs were identified previously, and several studies that have investigated their biological effects including antiviral properties have been reported [17] . In contrast, one avian type III IFN, chicken IFN-λ, was cloned recently [12] . Chicken IFN-λ has been reported to inhibit the replication of avian influenza A virus in cultured cells. However, no significant effects on the expression of ISGs could be detected. Therefore, we compared the effects of chicken type III IFN (IFN-λ) with those of type I (IFN-β) and type II (IFN-γ) IFNs on transcription of ISGs using recombinant proteins expressed in Escherichia coli in the present study to characterize the biological effects of chicken IFN-λ.
MATERIALS AND METHODS
Cell culture: CEFs obtained from White Leghorns were cultured in Dulbecco's modified Eagle's medium (SigmaAldrich, St. Louis, MO, U.S.A.) containing 10% fetal bovine serum (FBS) (Life Technologies, Carlsbad, CA, U.S.A.) and 1% penicillin/streptomycin solution (Nacalai Tesque, Tokyo, Japan) at 37°C in 5% CO 2 . A chicken macrophage cell line, HD11 cells, was cultured in Iscove's modified Dulbecco's medium (Sigma-Aldrich) containing 10% FBS and 1% penicillin/streptomycin solution at 37°C and 5% CO 2 .
Plaque formation assay: Confluent culture of CEFs in 6-well plates was treated with or without recombinant chicken IFN-λ for 12 hr, inoculated with 54 pfu/well of influenza virus A/whistling swan/Shimane/499/83 (H5N3) for 1 hr, and incubated in Eagle's minimal essential medium (Sigma Aldrich) containing 0.3% BSA, 1% agarose and 0.2 µg/ml trypsin for 4 days at 37°C in 5% CO 2 . The cells were fixed with 10% formalin for 1 hr and stained with 2% crystal violet, and formation of plaques was observed.
Cloning of chicken IFN cDNAs: HD11 cells were stimulated with 50 µg/ml poly (I:C) (GE Healthcare, Uppsala, Sweden), a synthetic double-stranded RNA that is used as a stimulant of TLR3 and MDA5 for induction of IFNs and ISGs [13] , for 6 hr, and total RNA of the cells was isolated using Trizol reagent (Life Technologies). Reverse transcription was performed with 1 µg total RNA, SuperScript III reverse transcriptase (Life Technologies), and an oligo dT primer according to the manufacturer's procedure. PCR was performed with 1 µl of first-strand cDNA, a primer pair listed in Table 1 and Taq polymerase (Ex Taq, Takara, Tokyo, Japan). The PCR profile was as follows: 30 cycles of 94°C for 30 sec, 60°C for 30 sec, and 72°C for 30 sec. All the PCR products were cloned into a pGEM-T Easy vector (Promega, Madison, WI, U.S.A.) and confirmed by sequencing with an ABI 3130 Genetic Analyzer (Life Technologies). Cloned plasmids containing cDNA of chicken IFNs were used for expressing the recombinant proteins. Expression and purification of recombinant chicken IFNs: Plasmids containing cDNA of chicken IFNs were digested with EcoRI and SalI (Takara), and cDNA fragments were purified from agarose gel, and ligated into a prokaryotic 6xHis-tagged protein expression vector, pET-28a (Merck, Darmstadt, Germany). An E. coli strain, Rosetta 2 (DE3) (Merck), was transformed with a chicken IFN cDNA-ligated pET-28a plasmid, and cultured in LB containing 50 µg/ml kanamycin at 37°C until the mid-log phase. Production of recombinant chicken IFNs was then induced by 1 mM isopropyl β-D-thiogalactoside for 15 hr, and the bacterial cells were recovered by centrifugation. The recovered cells were suspended in PBS containing 0.2% Triton X-100, sonicated, and centrifuged at 20,000 × g for 10 min. The pellet containing recombinant protein was dissolved in lysis buffer (6 M guanidine, 20 mM Na 2 HPO 4 , 0.5 M NaCl, pH 7.8). The recombinant chicken IFNs dissolved in lysis buffer were affinity-purified using Cobalt resin in a TALON purification kit (Clontech, Mountain View, CA, U.S.A.) according to the manufacturer's protocol. Fractions containing purified proteins were pooled and dialyzed for desalting and stored at −80°C until use.
Real-time quantitative RT-PCR: Cultured CEFs were treated with or without recombinant chicken IFNs or 50 µg/ ml poly (I:C), and used for isolation of total RNA. First- strand cDNA was reverse transcribed as described above. Real-time quantitative RT-PCR (qPCR) was performed with first strand cDNA, a primer pair listed in Table 1 and QuantiTect SYBR Green PCR Master Mix (Qiagen, Tokyo, Japan) in a LightCycler II system (Roche, Basel, Switzerland) according to the manufacturer's procedure. The PCR profile was as follows: 95°C for 15 min, followed by 35 cycles of 95°C for 15 sec, 55°C for 20 sec, and 72°C for 10 sec (GAPDH and Mx) or 95°C for 15 min, followed by 35 cycles of 95°C for 15 sec, 60°C for 20 sec, and 72°C for 10 sec (OAS). The dissociation curve of the PCR products was analyzed by increasing the temperature of samples from 65°C to 95°C after the quantitative PCR. The relative gene expression level was measured using the standard curve and normalized to the GAPDH expression level.
Statistical analysis: All values are presented as means ± SEM. Statistical analysis was performed by analysis of variance, followed by post hoc testing with Fisher's protected least significant difference multiple range test.
RESULTS

Biological effects of recombinant chicken IFN-λ:
We attempted compare the effect of IFN-λ on the mRNA expression of ISGs with those of chicken IFN-β and IFN-γ to characterize the biological properties of chicken type III IFN. In the beginning, we produced recombinant chicken IFN-β, IFN-γ and IFN-λ proteins. These proteins were 6xHis-tagged, expressed in E. coli and affinity-purified using cobalt resin as described in the Materials and methods. Next, we examined antiviral effect of recombinant IFN-λ on influenza virus (Fig. 1 ). CEFs were treated with or without IFN-λ for 12 hr prior to infection with influenza virus A/whistling swan/Shimane/499/83 (H5N3). Cytolytic plaques were observed CEFs not treated with IFN-λ. Cells treated with 1 or 10 ng/ml IFN-λ formed numbers of plaques comparable to non-treated cells. In contrast, the numbers of plaques were significantly reduced in the cells treated with 100 or 1,000 ng/ml IFN-λ. These results indicate that the recombinant IFN-λ produced in this study has a dose-dependent inhibitory effect on influenza virus.
Effects of recombinant chicken IFNs on the expression of ISGs:
To elucidate the effect of chicken IFNs on the expression of ISGs, we used real-time qPCR to measure the mRNA expression of Mx and OAS in CEFs following a 6 hr treatment with recombinant IFNs (Fig. 2) . The mRNA levels of both genes were normalized to the GAPDH mRNA level. Cells treated with 50 µg/ml Poly (I:C) for 6 hr were used as positive controls as described previously. The mRNA expression of both Mx and OAS increased significantly from 800-to 3,000-fold following treatment with poly (I:C). As shown in Fig. 2A , treatment with 1-10 ng/ml IFN-β did not increase the mRNA expression of Mx and OAS (0.6-to 1.2-fold compared with that of the controls). However, treatment with 100 ng/ml IFN-β increased Mx mRNA by 127.8-fold and OAS mRNA by 68.6-fold. Furthermore, treatment with 1,000 ng/ml IFN-β increased the mRNA expression of both genes by more than 400-fold, which was comparable to the increase in the mRNA expression obtained following treatment with poly (I:C). In contrast, Fig. 2B shows that treatment with 1 ng/ml IFN-γ tended to increase the mRNA expression of Mx and OAS (2.0-and 3.0-fold, respectively). The cells treated with 10 ng/ml IFN-γ showed a significant increase in OAS mRNA level (9.9-fold), while stimulation with higher doses (100 and 1,000 ng/ml) increased Mx and OAS mRNA levels by approximately 20-fold, which was lower than the increases obtained following treatment with poly (I:C) and IFN-β. Figure 2C shows the changes in mRNA levels of Mx and OAS after treatment with IFN-λ. When CEFs were treated with 1-10 ng/ml IFN-λ, mRNA levels were not increased (0.7-1.0-fold). Although stimulation with 100 ng/ml IFN-λ appeared to increase Mx and OAS mRNA levels (1.8 and 2.7 fold, respectively), it was not significant. However, 1,000 ng/ml IFN-λ induced a significant 33.5-fold increase in Mx mRNA and a 52.4-fold increase in OAS mRNA. These results indicate that the biological effects of chicken IFN-λ on the mRNA levels of the two genes are less than those of poly (I:C) or IFN-β, but comparable to those of IFN-γ.
Time course of mRNA expression of ISGs in IFN-λ-treated CEFs:
To investigate further the effect of IFN-λ on the expression of ISGs, we compared the time course of the mRNA expression of Mx and OAS in IFN-λ-treated CEFs with that in IFN-β-treated CEFs. As shown in Fig. 3A , the cells treated with 100 ng/ml IFN-β for 3 hr showed a significant increase in Mx (262-fold) and OAS (2,381-fold) mRNA levels. However, when the cells were treated with IFN-β for 24 hr, the mRNA levels of both genes were significantly lower than in the cells treated for 3 hr. In contrast, treatment with 1,000 ng/ ml IFN-λ for 3 hr induced a 14.1-fold increase in Mx mRNA and 41.3-fold increase in OAS mRNA (Fig. 3B) . In addition, when CEFs were treated with IFN-λ for 24 hr, the expression of both genes was further increased, and the expression of OAS mRNA and Mx mRNA increased by 66.4-fold and by 53.7-fold respectively, and both of which were higher than in the cells treated for 3 hr (Fig. 3B) .
DISCUSSION
IFNs are cytokines that act on both innate and adaptive immunity, thereby activating host defence mechanisms against viruses. A type III IFN, IFN-λ was recently identified in vertebrates. In birds, chicken IFN-λ was cloned previously, and its antiviral activity was reported [12] . However, most of the biological properties of chicken IFN-λ has not yet been clarified. In this study, we investigated the effect of chicken IFN-λ on the mRNA expression of Mx and OAS, which code for antiviral proteins. Previous studies have demonstrated that recombinant chicken IFNs produced by E. coli are active biologically [25] . Therefore, we obtained recombinant chicken IFN-β, IFN-γ, and IFN-λ from E. coli and analyzed their ISG-inducible properties in this study. As expected, the recombinant IFN-λ as well as IFN-β and γ used in this study induced the mRNA expression of Mx and OAS in CEFs in a dose-dependent manner. In addition, the recombinant IFN-λ inhibited replication of influenza virus in CEFs. These results indicate that the recombinant IFNs were biologically active in this study. In mammals, type III IFN is known to have biological effects similar to those of type I IFN. For example, human IFN-λ1 and IFN-λ2 have been shown to reduce replication of several viruses and induce the expression of the same ISGs that can be induced by type I IFN [1, 4, 20] . The present results are in agreement with these previous studies and indicate that avian type III IFN (IFN-λ) possesses antiviral properties, inducing ISGs in a manner similar to type I IFN.
In contrast, the present results also indicate that the effect of IFN-λ on the mRNA expression of Mx and OAS was different from IFN-β and IFN-γ, requiring a higher effective dose. Furthermore, the effect of IFN-λ on induction of ISGs was less than that of IFN-β, but comparable to that of IFN-γ. Previous reports have shown that mammalian type III IFN was less effective than type I IFN, corresponding to the present results [20, 32] . Recently, it was found that a soluble form of IFNLR1, which is produced by alternative splicing, could inhibit cellular IFN-λ1 responses [30] . IFN-λ1 could not induce the expression of MHC class I followed by phosphorylation of STAT1 and STAT3 in human peripheral blood mononuclear cells (PBMCs), which expressed soluble IFNLR1 mRNA to a similar extent as the membrane-bound IFNLR1 mRNA. In contrast, human keratinocytes and hepatocytes, which expressed soluble IFNLR1 mRNA at much lower levels compared with PBMCs, responded to IFN-λ1. A previous report revealed that chicken IFN-β could induce a significant increase in the mRNA expression of an ISG, TLR3, in chicken splenic mononuclear cells [12] . Soluble IFNLR1 may possibly inhibit the response to IFN-λ in certain cell types in chickens. Meanwhile, it was reported that IFN-λ could induce the mRNA expression of Mx and OAS but not PKR, an ISG that is induced by IFN-α, in human HCT116 cells [3] . Phosphorylation of STAT3 was not induced by IFN-λ but was induced by IFN-α in HCT116 cells. These differences in effects between chicken IFN-λ and IFN-β may be because of the differences in the signalling pathway between the two IFNs. Characterization of chicken IFNLR1, such as expression sites, regulation of alternative splicing and signalling pathways, is necessary to understand the difference in biological effects between type I and type III IFNs.
The time course of induction of Mx and OAS by IFN-λ was demonstrated in this study. The expression of both these genes continued to increase following 24 hr of stimulation with IFN-λ, but not IFN-β in CEFs. The sustained effect of IFN-λ on the expression of ISGs also appears to be different from that of type I IFN. Previous studies revealed that Mx mRNA expression peaked 6-8 hr after stimulation with type I IFN and subsequently declined [6, 8] . Our observations are consistent with the findings reported by Maher et al., which show that IFN-λ stimulation resulted in sustained activation of STAT1 and STAT2, and a continuous increase in the expression of ISGs including Mx at 24 hr in human HaCaT cells [18] . Considering the present results and those of the previous studies, prolonged activation of signal transduction by IFN-λ is also observed in chicken cells.
In the present study, we observed that not only IFN-β but also IFN-γ could induce the expression of Mx mRNA in CEFs. Since Mx was induced mainly by type I IFN and not by type II IFN in mammals [10] , the effect of chicken IFN-γ on the Mx gene appears unique to avian species. The present study suggests the possibility that the chicken Mx gene contains an IFN-γ response element or that chicken IFN-γ activates STATs in a manner similar to type I and III IFNs. Further studies, such as identification of the structure of IFN-γ-stimulated genes and the signaling pathway induced by IFN-γ, are necessary in bird species.
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